-
Company profile
-
Spheres of activities
-
Health
-
Environment
-
Culture
-
-
Strategy and management
-
Letter from Karl-Ludwig Kley
-
Values and external initiatives
-
Human rights
-
Responsible care
-
-
CR strategy and organization
-
Materiality analysis
-
Guidelines and management systems
-
Compliance
-
Stakeholder dialogue
-
-
Products
-
Product safety
-
Safety of drugs
-
Safety of chemical products
-
-
Product-related crime
-
Sustainable products
-
Packaging
-
Reuse and recycling
-
-
Access to health
-
Strategic approach
-
Neglected diseases
-
Pricing
-
Intellectual property
-
HIV Diagnostics
-
Philanthropy and product donations
-
-
Bioethics and biotechnology
-
Clinical trials
-
Animal testing
-
Responsible marketing
-
Interactions in the health care industry
-
Transport and storage safety
-
-
Suppliers
-
Management
-
Supply chain
-
-
Employees
-
Management
-
Good leadership
-
Diversity and inclusion
-
Recruiting and retaining talent
-
Employee engagement
-
Occupational health and safety
-
-
Environment
-
Management
-
Plant and process safety
-
Climate protection
-
Waste management
-
Resources
-
Water
-
Biodiversity
-
-
Society
-
Management
-
Schistosomiasis
-
Counterfeit pharmaceuticals
-
Deutsche Philharmonie Merck
-
Projects across the globe
-
-
Facts and figures
-
Report profile
-
Indicators
-
Economics
-
Compliance
-
Products
-
Employees
-
Environment
-
Society
-
-
Goals
-
Recognition and rankings
-
GRI Index
-
Company and Report Profile
-
Economic Performance Indicators
-
Environmental Performance Indicators
-
Social Performance Indicators
-
-
Global Compact CoP
-
Assurance Report
-
Sitemap
-
Company profile
-
Spheres of activities
-
Strategy and management
-
Products
-
Suppliers
-
Employees
-
Environment
-
Society
-
Facts and figures
